Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

IKK2

From Wikipedia, the free encyclopedia
Protein-coding gene in the species Homo sapiens
IKBKB
Available structures
PDBOrtholog search:PDBeRCSB
List of PDB id codes

4KIK,3BRT,3BRV,4E3C

Identifiers
AliasesIKBKB, IKK-beta, IKK2, IKKB, IMD15, NFKBIKB, inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, inhibitor of nuclear factor kappa B kinase subunit beta, IMD15A, IMD15B
External IDsOMIM:603258;MGI:1338071;HomoloGene:7782;GeneCards:IKBKB;OMA:IKBKB - orthologs
Gene location (Human)
Chromosome 8 (human)
Chr.Chromosome 8 (human)[1]
Chromosome 8 (human)
Genomic location for IKBKB
Genomic location for IKBKB
Band8p11.21Start42,271,302bp[1]
End42,332,460bp[1]
Gene location (Mouse)
Chromosome 8 (mouse)
Chr.Chromosome 8 (mouse)[2]
Chromosome 8 (mouse)
Genomic location for IKBKB
Genomic location for IKBKB
Band8|8 A2Start23,149,228bp[2]
End23,196,605bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • spleen

  • granulocyte

  • right lobe of thyroid gland

  • right uterine tube

  • skin of leg

  • skin of abdomen

  • minor salivary glands

  • left lobe of thyroid gland

  • tonsil

  • vagina
Top expressed in
  • mesenteric lymph nodes

  • blood

  • Paneth cell

  • crypt of lieberkuhn of small intestine

  • hair follicle

  • molar

  • medullary collecting duct

  • superior cervical ganglion

  • stroma of bone marrow

  • spleen
More reference expression data
BioGPS




More reference expression data
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo /QuickGO
Orthologs
SpeciesHumanMouse
Entrez

3551

16150

Ensembl

ENSG00000104365

ENSMUSG00000031537

UniProt

O14920

O88351

RefSeq (mRNA)

NM_001190720
NM_001190721
NM_001190722
NM_001242778
NM_001556

NM_001159774
NM_010546

RefSeq (protein)

NP_001177649
NP_001229707
NP_001547

NP_001153246
NP_034676

Location (UCSC)Chr 8: 42.27 – 42.33 MbChr 8: 23.15 – 23.2 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

IKK-β also known asinhibitor of nuclear factor kappa-B kinase subunit beta is aprotein that in humans is encoded by theIKBKB (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta)gene.

Function

[edit]
Main article:IκB kinase

IKK-β is anenzyme that serves as aprotein subunit ofIκB kinase, which is a component of thecytokine-activatedintracellular signaling pathway involved in triggeringimmune responses. IKK's activity causes activation of atranscription factor known as Nuclear Transcription factor kappa-B orNF-κB. Activated IKK-βphosphorylates a protein called theinhibitor of NF-κB,IκB (IκBα), which binds NF-κB to inhibit its function. Phosphorylated IκB isdegraded via theubiquitination pathway, freeing NF-κB, and allowing its entry into thenucleus of the cell where it activates various genes involved ininflammation and other immune responses.

Clinical significance

[edit]

IKK-β plays a significant role inbraincells following astroke.[5] IfNF-κB activation by IKK-β is blocked, damaged cells within the brain stay alive, and according to a study performed by theUniversity of Heidelberg and the University of Ulm, the cells even appear to make some recovery.[6]

Inhibition of IKK and IKK-related kinases has been investigated as a therapeutic option for the treatment of inflammatory diseases and cancer.[7] The small-molecule inhibitor of IKK2 SAR113945, developed by Sanofi-Aventis, was evaluated in patients with knee osteoarthritis.[8]

Interactions

[edit]

IKK-β (IKBKB) has been shown tointeract with

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000104365Ensembl, May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000031537Ensembl, May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, et al. (December 2005). "IKK mediates ischemia-induced neuronal death".Nature Medicine.11 (12):1322–9.doi:10.1038/nm1323.PMID 16286924.S2CID 28490303.
  6. ^"Stroke 'cell-death trigger' found".BBC News. 14 November 2005. RetrievedJune 28, 2007.
  7. ^Llona-Minguez S, Baiget J, Mackay SP (July 2013). "Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases".Pharmaceutical Patent Analyst.2 (4):481–98.doi:10.4155/ppa.13.31.PMID 24237125.
  8. ^"SAR113945 published clinical trials".
  9. ^Asare Y, Campbell-James TA, Bokov Y, Yu LL, Prestel M, El Bounkari O, et al. (August 2020)."Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability".Circulation Research.127 (6):811–823.doi:10.1161/CIRCRESAHA.120.316743.PMID 32546048.S2CID 219726725.
  10. ^abcChen G, Cao P, Goeddel DV (February 2002)."TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90".Molecular Cell.9 (2):401–10.doi:10.1016/S1097-2765(02)00450-1.PMID 11864612.
  11. ^Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M (October 1997)."The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation".Cell.91 (2):243–52.doi:10.1016/S0092-8674(00)80406-7.PMID 9346241.S2CID 6399108.
  12. ^abOtsuki T, Young DB, Sasaki DT, Pando MP, Li J, Manning A, et al. (2002)."Fanconi anemia protein complex is a novel target of the IKK signalsome".Journal of Cellular Biochemistry.86 (4):613–23.doi:10.1002/jcb.10270.PMID 12210728.S2CID 42471384.
  13. ^May MJ, D'Acquisto F, Madge LA, Glöckner J, Pober JS, Ghosh S (September 2000). "Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex".Science.289 (5484):1550–4.Bibcode:2000Sci...289.1550M.doi:10.1126/science.289.5484.1550.PMID 10968790.
  14. ^abcdWoronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV (October 1997). "IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK".Science.278 (5339):866–9.Bibcode:1997Sci...278..866W.doi:10.1126/science.278.5339.866.PMID 9346485.
  15. ^abDeng L, Wang C, Spencer E, Yang L, Braun A, You J, et al. (October 2000)."Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain".Cell.103 (2):351–61.doi:10.1016/S0092-8674(00)00126-4.PMID 11057907.S2CID 18154645.
  16. ^Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, et al. (November 2001)."Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation".Molecular and Cellular Biology.21 (21):7207–17.doi:10.1128/MCB.21.21.7207-7217.2001.PMC 99896.PMID 11585904.
  17. ^Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S,Gaynor RB (November 2001)."Regulation of beta-catenin function by the IkappaB kinases".The Journal of Biological Chemistry.276 (45):42276–86.doi:10.1074/jbc.M104227200.PMID 11527961.
  18. ^Chariot A, Leonardi A, Muller J, Bonif M, Brown K, Siebenlist U (October 2002)."Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases".The Journal of Biological Chemistry.277 (40):37029–36.doi:10.1074/jbc.M205069200.PMID 12133833.
  19. ^abWu RC, Qin J, Hashimoto Y, Wong J, Xu J, Tsai SY, et al. (May 2002)."Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase".Molecular and Cellular Biology.22 (10):3549–61.doi:10.1128/MCB.22.10.3549-3561.2002.PMC 133790.PMID 11971985.
  20. ^Shifera AS, Horwitz MS (March 2008). "Mutations in the zinc finger domain of IKK gamma block the activation of NF-kappa B and the induction of IL-2 in stimulated T lymphocytes".Molecular Immunology.45 (6):1633–45.doi:10.1016/j.molimm.2007.09.036.PMID 18207244.
  21. ^Vig E, Green M, Liu Y, Yu KY, Kwon HJ, Tian J, et al. (March 2001)."SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-kappaB activity".The Journal of Biological Chemistry.276 (11):7859–66.doi:10.1074/jbc.M010399200.PMID 11096118.
  22. ^Windheim M, Stafford M, Peggie M, Cohen P (March 2008)."Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase".Molecular and Cellular Biology.28 (5):1783–91.doi:10.1128/MCB.02380-06.PMC 2258775.PMID 18180283.
  23. ^Mercurio F, Murray BW, Shevchenko A, Bennett BL, Young DB, Li JW, et al. (February 1999)."IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex".Molecular and Cellular Biology.19 (2):1526–38.doi:10.1128/mcb.19.2.1526.PMC 116081.PMID 9891086.
  24. ^Cohen L, Henzel WJ, Baeuerle PA (September 1998). "IKAP is a scaffold protein of the IkappaB kinase complex".Nature.395 (6699):292–6.Bibcode:1998Natur.395..292C.doi:10.1038/26254.PMID 9751059.S2CID 4327300.
  25. ^Luftig MA, Cahir-McFarland E, Mosialos G, Kieff E (May 2001)."Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40".The Journal of Biological Chemistry.276 (18):14602–6.doi:10.1074/jbc.C100103200.PMID 11278268.
  26. ^Heissmeyer V, Krappmann D, Hatada EN, Scheidereit C (February 2001)."Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha".Molecular and Cellular Biology.21 (4):1024–35.doi:10.1128/MCB.21.4.1024-1035.2001.PMC 99557.PMID 11158290.
  27. ^Heissmeyer V, Krappmann D, Wulczyn FG, Scheidereit C (September 1999)."NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes".The EMBO Journal.18 (17):4766–78.doi:10.1093/emboj/18.17.4766.PMC 1171549.PMID 10469655.
  28. ^Prajapati S, Verma U, Yamamoto Y, Kwak YT, Gaynor RB (January 2004)."Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity".The Journal of Biological Chemistry.279 (3):1739–46.doi:10.1074/jbc.M306273200.PMID 14585847.
  29. ^Zhang SQ, Kovalenko A, Cantarella G, Wallach D (March 2000)."Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation".Immunity.12 (3):301–11.doi:10.1016/S1074-7613(00)80183-1.PMID 10755617.
  30. ^Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L (September 2000)."Activation of the NF-kappaB pathway by caspase 8 and its homologs".Oncogene.19 (39):4451–60.doi:10.1038/sj.onc.1203812.PMID 11002417.
  31. ^Devin A, Lin Y, Yamaoka S, Li Z, Karin M (June 2001)."The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF".Molecular and Cellular Biology.21 (12):3986–94.doi:10.1128/MCB.21.12.3986-3994.2001.PMC 87061.PMID 11359906.
  32. ^Li S, Wang L, Dorf ME (January 2009)."PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination".Molecular Cell.33 (1):30–42.doi:10.1016/j.molcel.2008.11.023.PMC 2643372.PMID 19150425.

See also

[edit]
Non-specific serine/threonine protein kinases (EC 2.7.11.1)
Pyruvate dehydrogenase kinase (EC 2.7.11.2)
Dephospho-(reductase kinase) kinase (EC 2.7.11.3)
3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring) kinase (EC 2.7.11.4)
(isocitrate dehydrogenase (NADP+)) kinase (EC 2.7.11.5)
(tyrosine 3-monooxygenase) kinase (EC 2.7.11.6)
Myosin-heavy-chain kinase (EC 2.7.11.7)
Fas-activated serine/threonine kinase (EC 2.7.11.8)
Goodpasture-antigen-binding protein kinase (EC 2.7.11.9)
  • -
IκB kinase (EC 2.7.11.10)
cAMP-dependent protein kinase (EC 2.7.11.11)
cGMP-dependent protein kinase (EC 2.7.11.12)
Protein kinase C (EC 2.7.11.13)
Rhodopsin kinase (EC 2.7.11.14)
Beta adrenergic receptor kinase (EC 2.7.11.15)
G-protein coupled receptor kinases (EC 2.7.11.16)
Ca2+/calmodulin-dependent (EC 2.7.11.17)
Myosin light-chain kinase (EC 2.7.11.18)
Phosphorylase kinase (EC 2.7.11.19)
Elongation factor 2 kinase (EC 2.7.11.20)
Polo kinase (EC 2.7.11.21)
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
Polo kinase (EC 2.7.11.21)
Cyclin-dependent kinase (EC 2.7.11.22)
(RNA-polymerase)-subunit kinase (EC 2.7.11.23)
Mitogen-activated protein kinase (EC 2.7.11.24)
MAP3K (EC 2.7.11.25)
Tau-protein kinase (EC 2.7.11.26)
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27)
  • -
Tropomyosin kinase (EC 2.7.11.28)
  • -
Low-density-lipoprotein receptor kinase (EC 2.7.11.29)
  • -
Receptor protein serine/threonine kinase (EC 2.7.11.30)
MAP2K
Activity
Regulation
Classification
Kinetics
Types
Portal:
Retrieved from "https://en.wikipedia.org/w/index.php?title=IKK2&oldid=1311679709"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp